Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

1. Long-Term Sewage Survey of SARS-CoV-2, Influenza A and Respiratory Syncytial Virus (RSV), and Correlation to Human Cases in a City with One Million Inhabitants.Microorganisms · 2025
   Article
2. Modeling the transmission mitigation impact of testing for infectious diseases.Science advances · 2024
   Article
3. Robust and sensitive amplicon-based whole-genome sequencing assay of respiratory syncytial virus subtype A and B.Microbiology spectrum · 2024
   Article
4. Modeling the Transmission Mitigation Impact of Testing for Infectious Diseases.medRxiv : the preprint server for health sciences · 2024
   Article
5. Recommendations for respiratory syncytial virus surveillance at the national level.The European respiratory journal · 2021
   Article
6. Polymicrobial Interactions Operative during Pathogen Transmission.mBio · 2021
   Review
7. Targeted antiviral treatment using non-ionizing radiation therapy for SARS-CoV-2 and viral pandemics preparedness: Technique, methods and practical notes for clinical application.PloS one · 2021
   Article
8. Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting.Vaccine: X · 2020
   Article
9. Risk factors and patterns of household clusters of respiratory viruses in rural Nepal.Epidemiology and infection · 2019
   Article
10. Model-based estimates of transmission of respiratory syncytial virus within households.Epidemics · 2019
    Article
11. Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
12. Continuous Invasion by Respiratory Viruses Observed in Rural Households During a Respiratory Syncytial Virus Seasonal Outbreak in Coastal Kenya.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
13. Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study.Wellcome open research · 2016
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 4 institutions in 4 countries.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as